Bioventix PLC (LON:BVXP - Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 4,148.89 ($54.01) and traded as low as GBX 3,625 ($47.19). Bioventix shares last traded at GBX 3,735 ($48.62), with a volume of 12,942 shares changing hands.
Bioventix Trading Up 3.8 %
The stock has a market cap of £197.73 million, a PE ratio of 2,296.93 and a beta of 0.35. The firm has a fifty day simple moving average of GBX 3,817.65 and a two-hundred day simple moving average of GBX 4,148.89.
Bioventix Increases Dividend
The business also recently announced a dividend, which will be paid on Thursday, November 21st. Shareholders of record on Thursday, November 7th will be given a dividend of GBX 87 ($1.13) per share. The ex-dividend date is Thursday, November 7th. This is a positive change from Bioventix's previous dividend of $68.00. This represents a yield of 2.4%. Bioventix's payout ratio is presently 9,693.25%.
Insider Transactions at Bioventix
In other news, insider Bruce Hiscock purchased 300 shares of the stock in a transaction on Wednesday, October 30th. The shares were acquired at an average price of GBX 3,330 ($43.35) per share, for a total transaction of £9,990 ($13,004.43). Insiders own 8.02% of the company's stock.
About Bioventix
(
Get Free Report)
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Read More
Before you consider Bioventix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.
While Bioventix currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
